Can Glycans Unlock The Secret To Proactive Personal Health Care?

1 min read

Key Takeaways:

  • GlycanAge is a Newcastle-based startup that’s revolutionizing proactive personal healthcare with its highly innovative focus on glycans, essential biomarkers in the health industry.
  • By offering a simple take-home test, GlycanAge allows individuals to measure their glycan levels easily, aiding in the identification and prevention of various health issues a decade before their occurrence.
  • The startup stands out in the biotechnology, health care, and personal health industries with its pioneering glycobiology research and innovative approach to personal health diagnostics.
  • The proactive healthcare industry is set to expand on a large scale in the future, with GlycanAge leading the way in the revolution.

The United Kingdom’s health care industry has welcomed a groundbreaking player. Operating from Newcastle Upon Tyne, GlycanAge is a startup that seamlessly combines biotechnology, health diagnostics, and personal health to yield revolutionary products. Founded by Gordan Lauc and Nikolina Lauc, this thriving company focuses on shifting healthcare from a reactive to a proactive approach, primarily through the study and application of glycans.

Glycans are biomarkers and play a crucial role in health and long-term well-being. By identifying changes in glycans a decade before common health issues such as cardiovascular diseases, hypertension, and insulin resistance occur, GlycanAge enables early prevention, changing the rules of personal healthcare.

What sets GlycanAge apart from other startups in the healthcare industry is their unique and groundbreaking focus on glycobiology. Instead of adhering to the conventional medical approach of treating symptoms, GlycanAge concentrates on diagnostic prevention. Their take-home test kit measures glycan levels, potentially identifying future health risks years in advance and promoting longevity.

Read more from UKT News:  Can Blockchain Revolutionise Mobile Payments and Transaction Processing in FinTech?

The biotechnology they employ is best-in-class, exemplifying the company’s commitment to high-quality service. The home test is simple, convenient, and effective, making it possible for everyone to keep track of their health in a proactive, preventive manner. This pioneering effort in the realm of personal healthcare emphasizes GlycanAge’s innovative spirit.

The future of GlycanAge, and indeed the industry it inhabits, looks bright. As advances in technology pave the way for more in-depth research and more accurate results, GlycanAge is anticipated to lead the transition from reactive to proactive healthcare industry, unlocking a multi-trillion dollar opportunity in the process.

The journey of GlycanAge points towards an era of proactive personal healthcare, where prevention reigns supreme. To stay updated with this thrilling journey, follow GlycanAge on Twitter at https://twitter.com/glycanage, on Facebook at https://www.facebook.com/glycanage/, and on LinkedIn at https://www.linkedin.com/company/glycanage-ltd. You can also learn more about their services through their website at https://glycanage.com/.


Want to supercharge your brand’s visibility within the UK tech industry? Reach startup founders, investors, and C-level executives with sponsored articles on UKT.news. Connect with us and discover how our advertising solutions can propel your brand to new heights. Explore our Sponsored Articles & Partnerships Program here.

Read more from UKT News:  Startup Showcase: EcoNomad Solutions - Innovating for Sustainable Smallholder Farming

UKT News

UKT.news is a media platform owned by Unstructured Media, providing the latest news and insights on UK technology and startup scenes. The website offers readers with daily updates on the latest industry developments, as well as featuring exciting startups and advertising opportunities.

Leave a Reply

Your email address will not be published.